Induction of Antigen-Specific Tolerance for the Treatment of Ongoing, Relapsing Autoimmune Encephalomyelitis: A Comparison between Oral and Peripheral Tolerance

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 1036-1044

  Kennedy, Kevin J ^a   Smith, Wendy S ^a   Miller, Stephen D ^a   Karpus, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; MYELIN PROTEIN; PEPTIDE FRAGMENT; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 139 151; PROTEOLIPID PROTEIN 139-151;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; COMPARATIVE STUDY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOUSE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; FEMALE; IMMUNE TOLERANCE; MICE; MYELIN PROTEINS; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS;

EID: 0031570934     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Arnason, B. G. 1983. Relevance of experimental allergic encephalomyelitis to multiple sclerosis. Neurol. Clin. 1:765.
2. Gonatas, N. K., M. I. Greene, and B. H. Waksman. 1986. Genetic and molecular aspects of demyelination. Immunol. Today 7:121.
3. Tuohy, V. K., R. A. Sobel, Z., Lu, R. A. Laursen, and M. B. Lees. 1992. Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J. Neuroimmunol. 39:67.
4. Satoh, J., F. Koike, and T. Tabira. 1988. Experimental allergic encephalomyelitis mediated by murine encephalitogenic T-cell lines specific for myelin proteolipid apoprotein. Ann. NY Acad. Sci. 540:343.
5. McRae, B. L., M. K. Kennedy, L. J. Tan, M. C. Dal Canto, and S. D. Miller. 1992. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:229.
6. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63:162.
7. + T cell-mediated pathology. J. Immunol. 156:4050.
8. Weiner, H. L. 1994. Oral tolerance. Proc. Natl. Acad. Sci. USA 91:10762.
9. + T lymphocytes. J. Immunol. 142:748.
10. Bitar, D. M., and C. C. Whitacre. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112:364.
11. Nussenblatt, R. B., R. R. Caspi, R. Mahdi, C.-C. Chan, F. Roberge, O. Lider, and H. L. Weiner. 1990. Inhibition of S-antigen-induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144:1689.
12. Zhang, Z. Y., C. S. Lee, O. Lider, and H. L. Weiner. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145:2489.
13. Wang, Z.-Y., J. Huang, T. Olsson, B. He, and H. Link. 1995. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J. Neurol. Sci. 128:167.
14. Weiner, H. L., G. A. Mackin, M. Matsui, E. J. Orav, S. J. Khoury, D. M. Dawson, and D. A. Hafler. 1993. Double-blind pilot trial of oral tolerance with myelin antigens in multiple sclerosis. Science 259:1321.
15. Trentham, D. E., R. A. Dynesius-Trentham, E. J. Orav, D. Combitchi, C. Lorenzo, K. L. Sewell, D. A. Hafler, and H. L. Weiner. 1993. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261:1727.
16. Miller, S. D., and D. G. Hanson. 1979. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin. J. Immunol. 123: 2344.
17. Asherson, G. L., M. Zembala, M. A. C. C. Perera, B. Mayhew, and W. R. Thomas. 1977. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes, and other lymphoid tissues. Cell. Immunol. 33:145.
18. Strobel, S., A. M. Mowat, H. E. Drummond, M. G. Pickering, and A. Ferguson. 1983. Immunological responses to fed protein antigens in mice: oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology 49:451.
19. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, and D. M. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147:2155.
20. Miller, A., O. Lider, A. B. Roberts, M. B. Sporn, and H. L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89:421.
21. Friedman, A., and H. L. Weiner. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91:6688.
22. Michalek, S. M., J. R. McGhee, H. Kiyono, D. E. Colwell, J. H. Eldridge, M. J. Wannemuehler, and W. J. Koopman. 1983. The IgA response: inductive aspects, regulatory cells, and effector functions. Ann. NY Acad. Sci. 409:48.
23. Husby, S., J. Mestecky, Z., Moldoveanu, S. Holland, and C. O. Elson. 1994. Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J. Immunol. 152:4663.
24. Elson, C. O., and W. Ealding. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133:2892.
25. Kay, R. A., and A. Ferguson. 1989. The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology 66:416.
26. Sun, J.-B., J. Holmgren, and C. Czerkinsky. 1994. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91:10795.
27. Weiner, H. L. 1993. Treatment of autoimmune diseases by oral tolerance to autoantigens. Autoimmunity 15:6.
28. Peterson, J. D., W. J. Karpus, R. J. Clatch, and S. D. Miller. 1993. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23:46.
29. Miller, S. D., L. J. Tan, L. Pope, B. L. McRae, and W. J. Karpus. 1992. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis. Int. Rev. Immunol. 9:203.
30. Weiner, H. L., A. Friedman, A. Miller, S. J. Khoury, A. Al-Sabbagh, L. Santos, M. Saycgh, R. B. Nussenblatt, D. E. Trentham, and D. A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. Immunol. 12:809.
31. + Th1 but not Th2 cytokine responses. Int. Immunol. 6:721.
32. Karpus, W. J., K. J. Kennedy, W. S. Smith, and S. D. Miller. 1996. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. J. Neurosci. Res. 45:410.
33. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J. Immunol. 146:1163.
34. Kuruvilla, A. P., R. Shah, G. M. Hochwald, H. D. Liggitt, M. A. Palladino, and G. J. Thorbecke. 1991. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA 88:2918.
35. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential up-regulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
36. Meyer, A. L., J. M. Benson, I. E. Gienapp, K. L. Cox, and C. C. Whitacre. 1996. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J. Immunol. 157:4230.
37. Chen, Y., J. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo, and H. L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
38. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237.
39. Higgins, P. J., and H. L. Weiner. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein and its fragments. J. Immunol. 140:440.
40. Khare, S. D., C. J. Krco, M. M. Griffiths, H. S. Luthra, and C. S. David. 1995. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J. Immunol. 155:3653.
41. Tan, L.-J., M. K. Kennedy, M. C. Dal Canto, and S. D. Miller. 1991. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance. J. Immunol. 147:1797.
42. Vandenbark, A. A., M. Vainiene, K. Ariail, S. D. Miller, and H. Offner. 1996. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes. J. Neurosci. Res. 45:430.
43. Karpus, W. J., J. G. Pope, J. D. Peterson, M. C. Dal Canto, and S. D. Miller. 1995. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155:947.
44. Braley-Mullen, H., J. G. Tompson, G. C. Sharp, and M. Kyriakos. 1980. Suppression of experimental autoimmune thyroiditis in guinea pigs by pretreatment with thyroglobulin-coupled spleen cells. Cell. Immunol. 51:408.
45. Dua, H. S., D. S. Gregerson, and L. A. Donoso. 1992. Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells. Cell. Immunol. 139:292.
46. Gregorian, S. K., L. Clark, E. Heber-Kalz, E. P. Amento, and A. Rostami. 1993. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis. Cell. Immunol. 150:298.
47. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
48. Blanas, E., F. R. Carbone, J. Allison, and J. F. A. P. Miller. 1996. Induction of autoimmune diabetes by oral administration of autoantigen. Science 274:1707.
49. + suppressor cells differentially affect the production of IFN-γ by effector cells of experimental autoimmune encephalomyelitis. J. Immunol. 143:3492.
50. Kuchroo, V. K., C. A. Martin, J. M. Greer, S.-T. Ju, R. A. Sobel, and M. E. Dorf. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:4371.
51. Panitch, H. S., A. S. Haley, R. L. Hirsch, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1:893.
52. + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA 92:11931.
53. Burstein, H. J., C. M. Shea, and A. K. Abbas. 1992. Aqueous antigens induce in vivo tolerance selectivity in IL-2-and IFN-γ-producing (Th1) cells. J. Immunol. 148:3687.
54. Brocke, S., K. Gijbels, M. Allegretta, I. Feber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell, T. Veromaa, A. Waisman, A. Gaur, P. Conlon, N. Ling, P. J. Fairchild, D. C. Wraith, A. O'Garra, C. G. Fathman, and L. Steinman. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
55. Garside, P., M. Steel, E. A. Worthey, A. Satoskar, J. Alexander, H. Bluethmann, F. Y. Liew, and A. M. Mowat. 1995. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154:5649.
56. Street, N. E., and T. R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine pattern. FASEB J. 5:171.
57. Miller, S. D., C. L. Vanderlugt, D. J. Lenschow, J. G. Pope, N. J. Karandikar, M. C. Dal Canto, and J. A. Bluestone. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739.
58. Vandenbark, A. A., B. Celnik, M. Vainiene, S. D. Miller, and H. Offner. 1995. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism. J. Immunol. 155:5861.
59. Yuschenkoff, V. N., M. P. Sethna, G. J. Freeman, and D. C. Parker. 1996. Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells. J. Immunol. 157:1987.
60. Perry, L. L., E. Barzaga-Gilbert, and J. L. Trotter. 1991. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 33:7.
61. Cross, A. H., V. K. Tuohy, and C. S. Raine. 1993. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cell. Immunol. 146:261.
62. Mor, F., and I. R. Cohen. 1993. Shifts in epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 92:2199.
63. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75.
64. Yu, M., J. M. Johnson, and V. K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777.
65. Wraith, D. C., D. E. Smilek, D. J. Mitchell, L. Steinman, and H. O. McDevitt. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247.
66. Kuchroo, V. K., J. M. Greer, D. Kaul, G. Ishioka, A. Franco, A. Sette, R. A. Sobel, and M. B. Lees. 1994. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 153:3326.